CDK2 and neuroblastoma: Previous work has shown that all-trans retinoic acid (ATRA) promotes cell differentiation and reduces cell proliferation in some neuroblastoma (NB) cell lines, possibly by increased expression of p27Kip1, an inhibitor of CDK2, 4 and 67.